XML 59 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 71,303 $ 56,283
API and bulk drug product price true-up 66,474
Acquired in-process research and development asset 35,000
Payroll and related accruals 17,782 20,909
Accrued co-promotion expenses - current 733 3,176
Contract liabilities to pharmaceutical distributors 7,058 7,895
Roxadustat profit share to AstraZeneca 31,883 25,746
Property taxes and other taxes 7,685 12,610
Professional services 6,184 6,074
Other 4,704 4,906
Total accrued and other current liabilities $ 213,806 $ 172,599